Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SeaSpine is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The company's portfolio includes a comprehensive range of spinal implants and orthobiologics, such as demineralized bone matrix (DBM) and synthetic bone grafts. Following its merger with Orthofix in 2023, SeaSpine operates as a key division within the combined entity, providing surgeons with integrated procedural solutions for spinal fusion and fixation. The company is known for its innovative 7D Flash Navigation System, which uses machine-vision technology to improve surgical accuracy and efficiency. SeaSpine's products address a wide array of indications, including degenerative disc disease, spinal stenosis, and complex spinal deformities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seaspin.